Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Charles

Showing results (411-420 of 519) with videos related to

Pageof 52
Sort By:
Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2024
Editor's Note: Detection of Wilms' Tumor Antigen-Specific CTL in Tumor-Draining Lymph Nodes of Patients with Early Breast CancerRoopinder Gillmore, Shao-An Xue, Angelika Holler, et al.
British Journal of Cancer|September 10, 2022
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancerDaniel Fernandez-Garcia, Georgios Nteliopoulos, Robert K Hastings, et al.
International Journal of Cancer|November 4, 2004
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 yearsMartin J Slade, Anjana Singh, Brendan M Smith, et al.
Nanoscale|June 4, 2019
Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cellsPakatip Ruenraroengsak, Darya Kiryushko, Ioannis G Theodorou, et al.
The American Journal of Pathology|July 19, 2011
ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancerYoshiya Horimoto, Johan Hartman, Julie Millour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancerRoopinder Gillmore, Shao-An Xue, Angelika Holler, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
Breast Cancer Research and Treatment|January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Biochimica Et Biophysica Acta|April 29, 1987
Reciprocal regulation of glutamine synthetase and carbamoylphosphate synthetase levels in rat liverC J de Groot, G H ten Voorde, R E van Andel, et al.
Pageof 52

Showing results (411-420 of 519) with videos related to

Sort By:
Pageof 52
Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2024
Editor's Note: Detection of Wilms' Tumor Antigen-Specific CTL in Tumor-Draining Lymph Nodes of Patients with Early Breast CancerRoopinder Gillmore, Shao-An Xue, Angelika Holler, et al.
British Journal of Cancer|September 10, 2022
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancerDaniel Fernandez-Garcia, Georgios Nteliopoulos, Robert K Hastings, et al.
International Journal of Cancer|November 4, 2004
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 yearsMartin J Slade, Anjana Singh, Brendan M Smith, et al.
Nanoscale|June 4, 2019
Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cellsPakatip Ruenraroengsak, Darya Kiryushko, Ioannis G Theodorou, et al.
The American Journal of Pathology|July 19, 2011
ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancerYoshiya Horimoto, Johan Hartman, Julie Millour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancerRoopinder Gillmore, Shao-An Xue, Angelika Holler, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
Breast Cancer Research and Treatment|January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Biochimica Et Biophysica Acta|April 29, 1987
Reciprocal regulation of glutamine synthetase and carbamoylphosphate synthetase levels in rat liverC J de Groot, G H ten Voorde, R E van Andel, et al.
Pageof 52